Skip to main content
. 2022 Dec 27;59(1):56. doi: 10.3390/medicina59010056

Table 1.

Risk factors for antimalarial-induced ocular toxicity [5,32].

  1. Daily HCQ dose > 5 mg/kg (real weight)

  2. CQ dose > 2.3 mg/kg (real weight)

  3. Daily HCQ dose >6.5 mg/kg of ideal weight in obese patients

  4. Use for >5 years

  5. Cumulative dose > 600–1000 g

  6. CKD stage 3, 4, or 5

  7. Concomitant tamoxifen for >6 months

  8. Macular degeneration, retinal dystrophy, cataracts